CA3071226A1 - A process for preparation of triaminopyrimidine compound and intermediates thereof - Google Patents
A process for preparation of triaminopyrimidine compound and intermediates thereof Download PDFInfo
- Publication number
- CA3071226A1 CA3071226A1 CA3071226A CA3071226A CA3071226A1 CA 3071226 A1 CA3071226 A1 CA 3071226A1 CA 3071226 A CA3071226 A CA 3071226A CA 3071226 A CA3071226 A CA 3071226A CA 3071226 A1 CA3071226 A1 CA 3071226A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- triaminopyrimidine
- solvents
- reacting
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721031453 | 2017-09-05 | ||
| IN201721031453 | 2017-09-05 | ||
| IN201721034342 | 2017-09-27 | ||
| IN201721034342 | 2017-09-27 | ||
| PCT/IB2018/056732 WO2019049021A1 (en) | 2017-09-05 | 2018-09-04 | PROCESS FOR THE PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND ITS INTERMEDIATES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3071226A1 true CA3071226A1 (en) | 2019-03-14 |
Family
ID=63684213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3071226A Pending CA3071226A1 (en) | 2017-09-05 | 2018-09-04 | A process for preparation of triaminopyrimidine compound and intermediates thereof |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12378223B2 (enExample) |
| EP (1) | EP3679030B1 (enExample) |
| JP (1) | JP2020532513A (enExample) |
| CN (1) | CN111051299A (enExample) |
| CA (1) | CA3071226A1 (enExample) |
| ES (1) | ES2979379T3 (enExample) |
| MX (2) | MX2020002142A (enExample) |
| PH (1) | PH12020500385A1 (enExample) |
| WO (1) | WO2019049021A1 (enExample) |
| ZA (1) | ZA202000903B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025115034A1 (en) * | 2023-11-30 | 2025-06-05 | Zydus Lifesciences Limited | A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58124B1 (sr) * | 2014-04-28 | 2019-02-28 | Medicines For Malaria Venture Mmv | Triaminopirimidin jedinjenja korisna za prevenciju ili tretman malarije |
-
2018
- 2018-09-04 EP EP18778565.4A patent/EP3679030B1/en active Active
- 2018-09-04 US US16/640,491 patent/US12378223B2/en active Active
- 2018-09-04 JP JP2020511759A patent/JP2020532513A/ja not_active Withdrawn
- 2018-09-04 CN CN201880055980.1A patent/CN111051299A/zh active Pending
- 2018-09-04 MX MX2020002142A patent/MX2020002142A/es unknown
- 2018-09-04 ES ES18778565T patent/ES2979379T3/es active Active
- 2018-09-04 CA CA3071226A patent/CA3071226A1/en active Pending
- 2018-09-04 WO PCT/IB2018/056732 patent/WO2019049021A1/en not_active Ceased
-
2020
- 2020-02-12 ZA ZA2020/00903A patent/ZA202000903B/en unknown
- 2020-02-25 MX MX2024002113A patent/MX2024002113A/es unknown
- 2020-02-27 PH PH12020500385A patent/PH12020500385A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202000903B (en) | 2024-07-31 |
| EP3679030B1 (en) | 2024-03-27 |
| US12378223B2 (en) | 2025-08-05 |
| EP3679030A1 (en) | 2020-07-15 |
| JP2020532513A (ja) | 2020-11-12 |
| MX2024002113A (es) | 2024-03-06 |
| PH12020500385A1 (en) | 2020-12-07 |
| CN111051299A (zh) | 2020-04-21 |
| US20200207738A1 (en) | 2020-07-02 |
| BR112020003557A2 (pt) | 2020-09-01 |
| WO2019049021A1 (en) | 2019-03-14 |
| ES2979379T3 (es) | 2024-09-25 |
| MX2020002142A (es) | 2020-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102325775B1 (ko) | 5-클로로-ｎ2-(2-이소프로폭시-5-메틸-4-피페리딘-4-일-페닐)-ｎ4[2-(프로판-2-술포닐)-페닐]-피리미딘-2,4-디아민의 결정질 형태 | |
| US8835461B2 (en) | Substituted 3-hydroxy-4-pyridone derivative | |
| US20100016590A1 (en) | Nilotinib intermediates and preparation thereof | |
| US20070142436A1 (en) | New salt and polymorph of a DPP-IV inhibitor | |
| US20040010151A1 (en) | Lansoprazole polymorphs and processes for preparation thereof | |
| US20110040090A1 (en) | Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides | |
| KR20180114227A (ko) | 피리디닐아미노피리미딘 유도체의 메실레이트 염의 결정질 형태, 그의 제조 방법, 및 그의 용도 | |
| US9790185B2 (en) | Process for the preparation of regorafenib and its crystalline forms | |
| US20140221652A1 (en) | Improved process for preparation of imatinib and its mesylate salt | |
| US10144708B2 (en) | Crystalline arylalkylamine compound and process for producing the same | |
| US20250282729A1 (en) | Chemical compound manufacture, new salt form, and therapeutic uses thereof | |
| EP1988089A1 (en) | Imatinib base, and imatinib mesylate and processes for preparation thereof | |
| US12378223B2 (en) | Process for preparation of triaminopyrimidine compound and intermediates thereof | |
| CN101137644A (zh) | 7-（2-（4-（3-三氟甲基-苯基）-1,2,3,6-四氢-吡啶-1-基）乙基）异喹啉苯磺酸盐、它的制备与治疗用途 | |
| WO2012090221A1 (en) | Novel salts of imatinib | |
| WO2020053795A2 (en) | Process for the preparation of acalabrutinib and its intermediates | |
| KR102484846B1 (ko) | 벤조피란 유도체의 정제방법, 이의 결정형 및 상기 결정형의 제조방법 | |
| CA2515130A1 (en) | Method of stabilizing lansoprazole | |
| BR112020003557B1 (pt) | Formas cristalinas de um composto de triaminopirimidina, processos para a preparação do referido composto, composto de triaminopirimidina apresentando as referidas formas cristalinas e composições compreendendo o referido composto | |
| US8193217B2 (en) | Polymorphic form of granisetron hydrochloride and methods of making the same | |
| CN106478603B (zh) | 尼洛替尼盐酸盐的新晶型及其制备方法和医药用途 | |
| US20250034095A1 (en) | New process for preparation of aficamten | |
| JP2021161097A (ja) | テネリグリプチンの新規結晶形及びその製造方法 | |
| KR20200069687A (ko) | 단백질 키나아제 저해제인 신규한 페녹시 아로마틱 아마이드 유도체 | |
| WO2014063752A1 (en) | Process for making crystalline form alpha of eletriptan hydrobromide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230817 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R11-R103 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUEST RECEIVED Effective date: 20240717 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240823 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240823 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240823 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20240924 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241203 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250120 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250214 |
|
| R13 | Change to the name of applicant or owner recorded |
Free format text: ST27 STATUS EVENT CODE: A-2-2-R10-R13-R104 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CHANGE OF NAME REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250612 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250626 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250626 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD Year of fee payment: 7 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250903 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250903 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260324 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260324 |